{
    "profile_id": "bastiaanevers",
    "first_name": "Bastiaan",
    "last_name": "Evers",
    "sub_title": "Senior Director Drug Discovery at Scenic Biotech",
    "profile_picture": null,
    "background_image": null,
    "profile_type": "personal",
    "entity_urn": "ACoAAAGQrtMBq7aHGMp2v5liYKll2U5nU0eykdo",
    "object_urn": 26259155,
    "birth_date": null,
    "summary": "I am an ambitious and versatile scientist/engineer with excellent analytical skills, an independent, critical and creative mindset, and a firm belief that emotional skills foster the best results in any organization. \n\nI have a strong focus on technology and find deep motivation in creating and applying novel, cutting edge technology to human health. In particular, I combine my educational background in biotechnology and molecular biology with thorough understanding and work experience in (bio)informatics which makes for the perfect combination to achieve my long term goal.\n\nMy goal is to use my creative analytical and engineering skills to increase understanding of or reduce suffering from human disease.",
    "location": {
        "country": "Netherlands",
        "short": "Amsterdam, North Holland",
        "city": "Amsterdam",
        "state": "North Holland",
        "default": "Amsterdam, North Holland, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": [
            {
                "name": "Dutch",
                "proficiency": "NATIVE_OR_BILINGUAL"
            },
            {
                "name": "English",
                "proficiency": "FULL_PROFESSIONAL"
            },
            {
                "name": "French",
                "proficiency": "LIMITED_WORKING"
            },
            {
                "name": "German",
                "proficiency": "LIMITED_WORKING"
            },
            {
                "name": "Spanish",
                "proficiency": "LIMITED_WORKING"
            },
            {
                "name": "Swedish",
                "proficiency": "ELEMENTARY"
            }
        ]
    },
    "industry": "Research",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1995
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2002
                }
            },
            "school": {
                "name": "Wageningen University & Research",
                "logo": "https://media.licdn.com/dms/image/C510BAQFQJQXtOy2Stw/company-logo_400_400/0/1519889640020?e=1700092800&v=beta&t=F6jKcJVPtd07jV7E4uIWxIb8orS74PhsrGgpnRI6txU",
                "url": "https://www.linkedin.com/school/wageningenuniversity/"
            },
            "degree_name": "Master of Science (MSc",
            "field_of_study": "Bioprocess engineering"
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1983
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1989
                }
            },
            "school": {
                "name": "Stedelijk Gymnasium Arnhem",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [],
    "organizations": [],
    "projects": [],
    "publications": [
        {
            "name": "CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes",
            "publisher": "Nat Biot",
            "url": "http://dx.doi.org/10.1038/nbt.3536",
            "date": {
                "month": null,
                "day": null,
                "year": 2016
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                }
            ]
        },
        {
            "name": "A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair",
            "publisher": "Cell Discovery",
            "url": "http://dx.doi.org/10.1038/celldisc.2015.34",
            "date": {
                "month": null,
                "day": null,
                "year": 2015
            },
            "authors": [
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Patrick Herr",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Thomas",
                    "last_name": "Helleday",
                    "name": null,
                    "headline": "Professor of Translational Medicine and Chemical Biology"
                }
            ]
        },
        {
            "name": "PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites",
            "publisher": "Oncogene",
            "url": "http://dx.doi.org/10.1038/onc.2015.135",
            "date": {
                "month": null,
                "day": null,
                "year": 2015
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Oliver",
                    "last_name": "Mortusewicz",
                    "name": null,
                    "headline": "Principal Researcher and Team leader at Karolinska Institutet"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Thomas",
                    "last_name": "Helleday",
                    "name": null,
                    "headline": "Professor of Translational Medicine and Chemical Biology"
                }
            ]
        },
        {
            "name": "PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs",
            "publisher": "Cell Reports",
            "url": "http://dx.doi.org/10.1016/j.celrep.2015.08.037",
            "date": {
                "month": null,
                "day": null,
                "year": 2015
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Anirudh",
                    "last_name": "Prahallad",
                    "name": null,
                    "headline": "Associate Director at Novartis"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Guus",
                    "last_name": "Heynen",
                    "name": null,
                    "headline": "Postdoctoral Researcher at Charit\u00e9 - University Medicine Berlin"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Rene",
                    "last_name": "Bernards",
                    "name": null,
                    "headline": "Founder and Chief Scientific Officer,  Agendia; Professor of Molecular Carcinogenesis, the Netherlands Cancer Institute"
                }
            ]
        },
        {
            "name": "Chronic Low Dose Rate Ionizing Radiation Exposure Induces Premature Senescence in Human Fibroblasts that Correlates with Up Regulation of Proteins Involved in Protection against Oxidative Stress",
            "publisher": "Proteomes",
            "url": "http://dx.doi.org/10.3390/proteomes2030341",
            "date": {
                "month": null,
                "day": null,
                "year": 2014
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Olga Loseva",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Thomas",
                    "last_name": "Helleday",
                    "name": null,
                    "headline": "Professor of Translational Medicine and Chemical Biology"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Mats Harms-Ringdahl",
                    "headline": null
                }
            ]
        },
        {
            "name": "MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool",
            "publisher": "Nature",
            "url": "http://dx.doi.org/10.1038/nature13181",
            "date": {
                "month": null,
                "day": null,
                "year": 2014
            },
            "authors": [
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Helge Gad",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Thomas",
                    "last_name": "Helleday",
                    "name": null,
                    "headline": "Professor of Translational Medicine and Chemical Biology"
                }
            ]
        },
        {
            "name": "The Good, the Bad, and the Ugly: in search of gold standards for assessing functional genetic screen quality",
            "publisher": "Mol Syst Biol",
            "url": "http://dx.doi.org/10.15252/msb.20145372",
            "date": {
                "month": null,
                "day": null,
                "year": 2014
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Rene",
                    "last_name": "Bernards",
                    "name": null,
                    "headline": "Founder and Chief Scientific Officer,  Agendia; Professor of Molecular Carcinogenesis, the Netherlands Cancer Institute"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Roderick",
                    "last_name": "Beijersbergen",
                    "name": null,
                    "headline": "Group leader at the Netherlands Cancer Institute, Professor Functional Genomics at Swammerdam Institute for Life Sciences, University of Amsterdam,  and  co-founder at Qameleon Therapeutics B.V."
                }
            ]
        },
        {
            "name": "A high throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors",
            "publisher": "Clin Cancer Res",
            "url": "http://dx.doi.org/10.1158/1078-0432.CCR-09-2434",
            "date": {
                "month": null,
                "day": null,
                "year": 2010
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                }
            ]
        },
        {
            "name": "A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesis",
            "publisher": "J Pathol",
            "url": "http://dx.doi.org/10.1002/path.2655",
            "date": {
                "month": null,
                "day": null,
                "year": 2010
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Karin",
                    "last_name": "de Visser",
                    "name": null,
                    "headline": "Group Leader at The Netherlands Cancer Institute and Oncode Institute, Professor at Leiden University"
                }
            ]
        },
        {
            "name": "Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis",
            "publisher": "Proc Natl Acad Sci U S A",
            "url": "http://dx.doi.org/10.1073/pnas.1222085110",
            "date": {
                "month": null,
                "day": null,
                "year": 2010
            },
            "authors": [
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "CJ Desmet",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Daniel Peeper",
                    "headline": null
                }
            ]
        },
        {
            "name": "Targeting homologous recombination repair defects in cancer",
            "publisher": "Trends Pharmacol Sci",
            "url": "http://dx.doi.org/10.1016/j.tips.2010.06.001",
            "date": {
                "month": null,
                "day": null,
                "year": 2010
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Thomas",
                    "last_name": "Helleday",
                    "name": null,
                    "headline": "Professor of Translational Medicine and Chemical Biology"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "jos jonkers",
                    "headline": null
                }
            ]
        },
        {
            "name": "BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A",
            "publisher": "Breast Cancer Res",
            "url": "http://dx.doi.org/10.1186%2Fbcr2354",
            "date": {
                "month": null,
                "day": null,
                "year": 2009
            },
            "authors": [
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "J Puppe",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Maarten van Lohuizen",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Alexandra",
                    "last_name": "Pietersen",
                    "name": null,
                    "headline": "Teacher"
                }
            ]
        },
        {
            "name": "Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice",
            "publisher": "Atherosclerosis",
            "url": "http://dx.doi.org/10.1016/j.atherosclerosis.2009.06.015",
            "date": {
                "month": null,
                "day": null,
                "year": 2009
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lianne",
                    "last_name": "Boesten",
                    "name": null,
                    "headline": "Laboratoriumspecialist Klinische Chemie endocrinoloog/ Afdelingshoofd Laboratoria IJsselland Ziekenhuis/Lid bestuursberaad IJsselland Ziekenhuis"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "MP de Winther",
                    "headline": null
                }
            ]
        },
        {
            "name": "Bmi1 Regulates Stem Cells and Proliferation and Differentiation of Committed Cells in Mammary Epithelium",
            "publisher": "Curr Biol",
            "url": "http://dx.doi.org/10.1016/j.cub.2008.06.070",
            "date": {
                "month": null,
                "day": null,
                "year": 2008
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Alexandra",
                    "last_name": "Pietersen",
                    "name": null,
                    "headline": "Teacher"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Maarten van Lohuizen",
                    "headline": null
                }
            ]
        },
        {
            "name": "Selective Inhibition of BRCA2-Deficient Mammary Tumor  Cell Growth by AZD2281 and Cisplatin",
            "publisher": "Clin Cancer Res",
            "url": "http://dx.doi.org/10.1158/1078-0432.CCR-07-4953",
            "date": {
                "month": null,
                "day": null,
                "year": 2008
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                }
            ]
        },
        {
            "name": "Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects",
            "publisher": "Oncogene",
            "url": "http://dx.doi.org/10.1038/sj.onc.1209871",
            "date": {
                "month": null,
                "day": null,
                "year": 2006
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                }
            ]
        },
        {
            "name": "Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis",
            "publisher": "Cancer Cell",
            "url": "http://dx.doi.org/10.1016/j.ccr.2006.09.013",
            "date": {
                "month": null,
                "day": null,
                "year": 2006
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Patrick",
                    "last_name": "Derksen",
                    "name": null,
                    "headline": "Professor Experimental & Preclinical Oncology"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bastiaan",
                    "last_name": "Evers",
                    "name": null,
                    "headline": "Senior Director Drug Discovery at Scenic Biotech"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jos",
                    "last_name": "Jonkers",
                    "name": null,
                    "headline": "Senior Group Leader, Division of Molecular Pathology, Netherlands Cancer institute"
                }
            ]
        }
    ],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": 12592190,
                "name": "Scenic Biotech",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQET4Qk0aoPHTA/company-logo_400_400/0/1538409755115?e=1700092800&v=beta&t=qpe_48rbuLbkBQRjAs0qkQ1keFbD-BEB6M9NfMZWdY4",
                "url": "https://www.linkedin.com/company/scenic-biotech/",
                "employees": {
                    "start": 11,
                    "end": 50
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 2017
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Amsterdam, North Holland, Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2020
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Scenic Biotech",
                    "description": null,
                    "title": "Senior Director Drug Discovery",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Amsterdam, the Netherlands",
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 2017
                        },
                        "end": {
                            "month": 1,
                            "day": null,
                            "year": 2020
                        }
                    },
                    "company": "Scenic Biotech",
                    "description": null,
                    "title": "Director Of Operations",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 8373242,
                "name": "The Netherlands Cancer Institute",
                "logo": "https://media.licdn.com/dms/image/C560BAQEqz4HPV21a-Q/company-logo_400_400/0/1519888856405?e=1700092800&v=beta&t=jNklwdrPg2Mgz8gVtQ9kqWjP7yNnSB-q0Ano-nCxN-c",
                "url": "https://www.linkedin.com/company/the-netherlands-cancer-institute/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2016
                },
                "end": {
                    "month": 3,
                    "day": null,
                    "year": 2017
                }
            },
            "profile_positions": [
                {
                    "location": "Amsterdam Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2016
                        },
                        "end": {
                            "month": 3,
                            "day": null,
                            "year": 2017
                        }
                    },
                    "company": "The Netherlands Cancer Institute",
                    "description": "In the group of Prof. Ren\u00e9 Bernards, I am currently combining technology development, mainly in the area of CRISPR/Cas9 based gene editing, with its application to discover new biology with the purpose of finding novel therapeutic targets for (bladder) cancer.",
                    "title": "Senior Postdoc",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 13611,
                "name": "Netherlands Cancer Institute",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQHUuJZ6w8XlAg/company-logo_400_400/0/1519856586588?e=1700092800&v=beta&t=u04EfRwRNvMCOIDXrEPtS1OCuDOfY9QTUUquvRBLuBc",
                "url": "https://www.linkedin.com/company/antoni-van-leeuwenhoek/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2015
                }
            },
            "profile_positions": [
                {
                    "location": "Amsterdam",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2013
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2015
                        }
                    },
                    "company": "Antoni van Leeuwenhoek",
                    "description": "In the group of Prof. Ren\u00e9 Bernards, I am currently combining technology development, mainly in the area of CRISPR/Cas9 based gene editing, with its application to discover new biology with the purpose of finding novel therapeutic targets for (bladder) cancer.",
                    "title": "Postdoctoral Fellow",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 5366,
                "name": "Karolinska Institutet",
                "logo": "https://media.licdn.com/dms/image/D4D0BAQEpfV0v7SxDsg/company-logo_400_400/0/1666272452897?e=1700092800&v=beta&t=z5nvCwU1-rZSIUHy3qiwneK2W8B5O0ZaFOtUsJlH3rY",
                "url": "https://www.linkedin.com/school/karolinska-institutet/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2012
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2012
                }
            },
            "profile_positions": [
                {
                    "location": "Stockholm, Sweden",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2012
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2012
                        }
                    },
                    "company": "Karolinska Institutet",
                    "description": "Based at the brand new science for life laboratory, under supervision of Prof. Thomas Helleday, my responsibilities were to set up a new lab and run small research team that would identify novel genetic interactions exploitable for cancer therapies.",
                    "title": "Team Leader Genetic Interactions",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 166164,
                "name": "Stockholm University",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQEDDr4dLuJjYw/company-logo_400_400/0/1651005531652?e=1700092800&v=beta&t=PPJU5eJzshgZG5GGJnYhg5CxtrwRPZuyYE20sbQzXJQ",
                "url": "https://www.linkedin.com/school/stockholm-university/",
                "employees": {
                    "start": 5001,
                    "end": 10000
                }
            },
            "date": {
                "start": {
                    "month": 7,
                    "day": null,
                    "year": 2011
                },
                "end": {
                    "month": 5,
                    "day": null,
                    "year": 2012
                }
            },
            "profile_positions": [
                {
                    "location": "Stockholm, Sweden",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2011
                        },
                        "end": {
                            "month": 5,
                            "day": null,
                            "year": 2012
                        }
                    },
                    "company": "Stockholm University",
                    "description": "Based at the brand new science for life laboratory, under supervision of Prof. Thomas Helleday, my responsibilities were to set up a new lab and run small research team that would identify novel genetic interactions exploitable for cancer therapies.",
                    "title": "Team Leader Genetic Interactions",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 4477,
                "name": "University of Oxford",
                "logo": "https://media.licdn.com/dms/image/C560BAQGwPZs3spXFqw/company-logo_400_400/0/1539693367639?e=1700092800&v=beta&t=57DAXQAhRt9EcaWBnuFZvp8a5dCjh2PBLlC8jE2G51c",
                "url": "https://www.linkedin.com/school/oxforduni/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 9,
                    "day": null,
                    "year": 2009
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2011
                }
            },
            "profile_positions": [
                {
                    "location": "Oxford, United Kingdom",
                    "date": {
                        "start": {
                            "month": 9,
                            "day": null,
                            "year": 2009
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2011
                        }
                    },
                    "company": "University of Oxford",
                    "description": "In the group of Prof. Thomas Helleday, I worked on setting up screening strategies to identify novel genetic interactions that could be exploited in the treatment of cancer.",
                    "title": "KWF Postdoctoral research fellow",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 13611,
                "name": "Netherlands Cancer Institute",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQHUuJZ6w8XlAg/company-logo_400_400/0/1519856586588?e=1700092800&v=beta&t=u04EfRwRNvMCOIDXrEPtS1OCuDOfY9QTUUquvRBLuBc",
                "url": "https://www.linkedin.com/company/antoni-van-leeuwenhoek/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 2,
                    "day": null,
                    "year": 2003
                },
                "end": {
                    "month": 8,
                    "day": null,
                    "year": 2009
                }
            },
            "profile_positions": [
                {
                    "location": "Amsterdam",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2003
                        },
                        "end": {
                            "month": 8,
                            "day": null,
                            "year": 2009
                        }
                    },
                    "company": "Antoni van Leeuwenhoek",
                    "description": "During my PhD, I investigated novel treatment strategies for hereditary breast cancer.",
                    "title": "PhD Student",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "BioPartner",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2001
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2002
                }
            },
            "profile_positions": [
                {
                    "location": "Ede",
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 2001
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 2002
                        }
                    },
                    "company": "BioPartner",
                    "description": "As part of my second specialization, in business administration, I designed and carried out, together with Maarten Lauwerijssen, research that provided better insights in the dynamics of entrepreneurship in life sciences. This research was done for BioPartner, an organization set up by the Dutch Ministry of Economic Affairs to increase entrepreneurship in the life science sector.",
                    "title": "Intern",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "PC International",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1995
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2001
                }
            },
            "profile_positions": [
                {
                    "location": "Wageningen",
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 1995
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 2001
                        }
                    },
                    "company": "PC International",
                    "description": "Throughout my study I worked on a part-time basis at this computer shop where I sold and repaired PCs.",
                    "title": "Sales rep.",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "I&I Information technology",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1998
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 1999
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": null,
                            "day": null,
                            "year": 1998
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": 1999
                        }
                    },
                    "company": "I&I Information technology",
                    "description": "In the period leading up to y2k, I&I consultancy created a unique project to fill in the temporary need for employment in the ICT sector. They selected 100 students with advanced skills in programming and computer management to help testing and improving computer systems and make sure customers would not suffer from widely anticipated problems commonly known as the millenium bug. I was posted at Civility where I functioned as an on-demand system administrator for city council computer systems.",
                    "title": "Systems consultant",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Molecular Biology",
        "Genetics",
        "Cell Biology",
        "Cancer",
        "Cell Culture",
        "Biochemistry",
        "Molecular Genetics",
        "Cancer Research",
        "qPCR",
        "Life Sciences",
        "Bioinformatics",
        "Science",
        "Western Blotting",
        "PCR",
        "Genomics",
        "Programming",
        "CRISPR"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}